Page last updated: 2024-11-05

xanthurenic acid and Migraine Disorders

xanthurenic acid has been researched along with Migraine Disorders in 1 studies

xanthurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by hydroxy groups at C-4 and C-8.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"These findings suggest that in migraine KYN is unidirectionally metabolized into ANA at expenses of KYNA and 3-HK."1.42Altered kynurenine pathway metabolites in serum of chronic migraine patients. ( Capi, M; Curto, M; Fazio, F; Giamberardino, MA; Lionetto, L; Martelletti, P; Negro, A; Nicoletti, F; Simmaco, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curto, M1
Lionetto, L1
Negro, A1
Capi, M1
Fazio, F1
Giamberardino, MA1
Simmaco, M1
Nicoletti, F1
Martelletti, P1

Other Studies

1 other study available for xanthurenic acid and Migraine Disorders

ArticleYear
Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    The journal of headache and pain, 2015, Volume: 17

    Topics: Adult; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Male; Middle Aged; Migr

2015